Robert Matheson - Concepedia

Author

Robert Matheson

Oregon Medical Research Center

Also Known As

R Matheson, R. Matheson, R. T. MATHESON, Robert Matheson, Robert T Matheson, Robert T. Matheson

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Oregon Medical Research Center Probity Medical Research Innovaderm (Canada)Saint Louis University Dalhousie University

About

Robert Matheson is an author at Oregon Medical Research Center specializing in medicine, dermatology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	665
2	Immunology	3	3	236
3	Health Sciences	1	1	22
4	Allergy	1	1	197
5	Clinical Nutrition	1	1	22

Robert Matheson

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Etanercept as Monotherapy in Patients with Psoriasis Craig L. Leonardi, JEROLD L. POWERS, Robert Matheson, New England Journal of Medicine	2003	1.2K
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis Craig L. Leonardi, Robert Matheson, Claus Zachariae, New England Journal of Medicine	2012	927
Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis Howard Sofen, Stacy Smith, Robert Matheson, Journal of Allergy and Clinical Immunology	2014	298
Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial Kim Papp, Jennifer Clay Cather, Les Rosoph, The Lancet MedicineSevere PsoriasisClinical DermatologySkin PharmacologyDermatology	2012	277
Evidence that a neutrophil–keratinocyte crosstalk is an early target of <scp>IL</scp>‐17A inhibition in psoriasis Kristian Reich, Kim Papp, Robert Matheson, Experimental Dermatology ImmunodeficienciesImmune RegulationImmunologyDermatologyImmune System	2015	197
Dosing With 5% Imiquimod Cream 3 Times per Week for the Treatment of Actinic Keratosis Neil J. Korman, Ron Moy, Mark Ling, Archives of Dermatology	2005	164
Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head Joseph L. Jorizzo, Scott M. Dinehart, Robert Matheson, Journal of the American Academy of Dermatology Actinic KeratosesOphthalmologyRandomized StudyImiquimod 5Dermatology	2007	117
A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis James G. Krueger, Mayte Suárez‐Fariñas, Inna Cueto, PLoS ONE	2015	99
Topical Methyl Aminolevulinate Photodynamic Therapy Using Red Light-Emitting Diode Light for Multiple Actinic Keratoses Rolf-Markus Szeimies, Robert Matheson, Steven A. Davis, Dermatologic Surgery	2009	87
Efficacy, tolerability, and pharmacodynamics of apremilast in recalcitrant plaque psoriasis: a phase II open-label study. Alice B. Gottlieb, Robert Matheson, Alan Menter, PubMed	2013	77

Page 1